Nutrition Scientists Float “Least-Harm Strategy” To Allow Health Claims
This article was originally published in The Tan Sheet
Executive Summary
Presenters at the IFT Wellness conference recommend that nutrition science move beyond randomized controlled trials – which typically are ill-suited to assess nutrient benefits – so development of new food and supplement products is not impeded.
You may also be interested in...
POM Wonderful Asks Court To Vacate “Draconian” FTC Order
The nearly three-year battle between FTC and POM Wonderful moves to a federal appeals court, where the pomegranate juice and supplement firm asks the judges to nix the commission’s order that POM conduct two randomized controlled trials to support disease-related health claims.
POM Wonderful Asks Court To Vacate “Draconian” FTC Order
The nearly three-year battle between FTC and POM Wonderful moves to a federal appeals court, where the pomegranate juice and supplement firm asks the judges to nix the commission’s order that POM conduct two randomized controlled trials to support disease-related health claims.
AHRQ Vitamin D/Calcium Report Draws Industry Fire
The U.S. Preventive Service Task Force releases a meta-analysis looking at whether available research supports an association between the use of vitamin D and calcium and fracture prevention. Trials of vitamin D use alone or with calcium showed no statistically significant reduction in fractures among subjects in the control groups, the panel found.